"Collagenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyze the degradation of collagen by acting on the peptide bonds.
| Descriptor ID |
D017364
|
| MeSH Number(s) |
D08.811.277.656.300.480.205 D08.811.277.656.675.374.205
|
| Concept/Terms |
Collagenases- Collagenases
- Collagen-Degrading Enzyme
- Collagen Degrading Enzyme
- Collagenase
- Collagen Peptidase
- Peptidase, Collagen
|
Below are MeSH descriptors whose meaning is more general than "Collagenases".
Below are MeSH descriptors whose meaning is more specific than "Collagenases".
This graph shows the total number of publications written about "Collagenases" by people in this website by year, and whether "Collagenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1998 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Collagenases" by people in Profiles.
-
Peyronie's disease: pharmacological treatments and limitations. Expert Rev Clin Pharmacol. 2021 Jun; 14(6):703-713.
-
Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease. Int J Impot Res. 2020 03; 32(2):257-258.
-
Review of non-surgical treatment options for Peyronie's disease. Int J Impot Res. 2012 Jan-Feb; 24(1):1-10.
-
Peyronie's disease: review of nonsurgical treatment options. Urol Clin North Am. 2011 May; 38(2):195-205.
-
Non-surgical therapy of Peyronie's disease. Asian J Androl. 2008 Jan; 10(1):79-87.
-
The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman. J Sex Med. 2007 Sep; 4(5):1209-13.
-
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1454-9.
-
Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma. J Orthop Res. 2003 Nov; 21(6):1063-70.
-
Review of current nonsurgical management of Peyronie's disease. Int J Impot Res. 2003 Oct; 15 Suppl 5:S113-20.
-
Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem. 2003 Jul 11; 278(28):25386-94.